A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup.
about
Methotrexate for high-grade osteosarcoma in children and young adultsMethotrexate for high-grade osteosarcoma in children and young adultsOsteosarcoma: Current Treatment and a Collaborative Pathway to SuccessA phase I study in paediatric patients to evaluate the safety and pharmacokinetics of SPI-77, a liposome encapsulated formulation of cisplatinImprovement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup.Intensive induction chemotherapy without methotrexate in adult patients with localized osteosarcoma: results of the Institut Gustave-Roussy phase II trialPresence of chemotherapy-induced toxicity predicts improved survival in patients with localised extremity osteosarcoma treated with doxorubicin and cisplatin: a report from the European Osteosarcoma Intergroup.Efficacy and safety of gemcitabine-docetaxel combination therapy for recurrent or refractory high-grade osteosarcoma in China: a retrospective study of 18 patients.Prognostic factors in the survival of patients diagnosed with primary non-metastatic osteosarcoma with a poor response to neoadjuvant chemotherapy.Pediatric Osteosarcoma: An Updated ReviewOsteosarcoma Overview.Current treatment of osteosarcoma.miR-155 inhibitor reduces the proliferation and migration in osteosarcoma MG-63 cellsClinical analysis of osteosarcoma patients treated with high-dose methotrexate-free neoadjuvant chemotherapy.Predictive factors for local recurrence in osteosarcoma: 540 patients with extremity tumors followed for minimum 2.5 years after neoadjuvant chemotherapy.Licensing and labelling of drugs in a paediatric oncology ward.Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials.Evaluation of intraarterial and intravenous cisplatin chemotherapy in the treatment of metastatic osteosarcoma using an orthotopic xenograft mouse model.Risk of amputation following limb salvage surgery with endoprosthetic replacement, in a consecutive series of 1261 patients.Custom megaprosthetic replacement for proximal tibial tumours.Effectiveness of multi-drug regimen chemotherapy treatment in osteosarcoma patients: a network meta-analysis of randomized controlled trialsFrontline treatment of localized osteosarcoma without methotrexate: results of the St. Jude Children's Research Hospital OS99 trialThe Current and Future Therapies for Human Osteosarcoma.Analysis of Prognostic Factors in High-Grade Osteosarcoma of the Extremities in Children: A 15-Year Single-Institution Experience.Patterns of care and survival for patients aged under 40 years with bone sarcoma in Britain, 1980-1994.A Randomized Comparison of two Short Intensive Chemotherapy Regimens in Children and Young Adults With Osteosarcoma: Results in Patients With Metastases: A Study of the European Osteosarcoma IntergroupQuality of life in survivors of a primary bone tumour: a systematic reviewComparison of the outcome of conventional osteosarcoma at two specialist international orthopaedic oncology centres.Population based survival rates for childhood cancer in Britain, 1980-91.Periosteal Osteosarcoma: A Review of 17 Cases with Mean Follow-up of 52 MonthsCytotoxic agents are detrimental to bone formed by distraction osteogenesisChemotherapy for osteosarcoma - where does it come from? What is it? Where is it going?Single institution retrospective review of perioperative chemotherapy in adult and adolescent patients with operable osteosarcoma.Developing a prognostic model for patients with localized osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate: A single-center experience of 237 patients.Growth in the lower limb following chemotherapy for a malignant primary bone tumour: a straight-line graph.Longitudinal growth following treatment for osteosarcoma.Management of infection following reconstruction in bone tumors.Factors associated with local recurrence in operated osteosarcomas: A retrospective evaluation of 95 cases from a tertiary care center in a resource challenged environment.FR901228 induces tumor regression associated with induction of Fas ligand and activation of Fas signaling in human osteosarcoma cells.Highly effective reduced toxicity dose-intensive pilot protocol for non-metastatic limb osteogenic sarcoma (SCOS 89).
P2860
Q24234472-90DE9171-A121-4574-B1BE-AB233677A3FAQ24241431-A089A3D8-1BAD-43CF-BA79-C4AF68490530Q26797555-2C9EB239-6CBB-4B56-8838-AF969C4C5BD8Q28362947-45573838-5470-4A57-B36B-65B546523E35Q33373879-BE5BB257-B680-41F8-A49B-C32AF7BD719EQ33393253-AF98A255-960E-4DD6-AF73-A428EF045247Q33397854-49DCDFEB-D634-4E88-A0BD-0E2F4E0C1204Q33400419-E30564E6-AF0C-46C4-BDC4-C404764F2385Q33555060-3895FE4F-BDA5-4F7C-871E-4ADF97B3AF4AQ33583291-FF51FAFB-E09F-4845-990B-6B5AA4771A6DQ33725511-32C0D401-33E4-4F6D-BD1C-8E75F53457E7Q34242261-3FBFDC7D-BC37-4EC6-9852-045DA441BE61Q34292411-FE5244B3-92E1-4CD3-8160-CF2E726642F4Q34305928-E01C5AB2-E611-4395-849D-9A55B59502CDQ34750535-2E928F4D-7FA4-4E51-B63E-80B7FDA938A0Q35219672-852B3DC4-57C7-49F0-8085-8E0917232484Q35988850-2C400713-FA67-48D6-BA4C-7E1865843300Q36078941-2126FED9-BBDF-4CCF-8D3D-0AB8813D70EBQ36280319-5FCE3EF7-3A06-44DF-835A-F557007D3CDEQ36290157-D46B8A25-3FBA-4BB8-96D7-E6F7A3B5BE9EQ36327357-1249C265-FC9F-43FC-AC68-930675A992A7Q36503647-6D0ED053-D286-4872-90FF-BC940F34494BQ36514299-B9616869-8F45-4FD0-8C3B-E6294CF07544Q36556924-9A6921BB-3A83-46D0-B7B6-012A3D3DD719Q36613417-4C2D349D-A7D1-4D3E-9B57-1BC623114C0DQ36673852-D08B8ECE-3E8F-4DA4-8433-03F63BA384A2Q36674002-6F59DB93-D094-4E13-8B1B-B44060F446DCQ36674407-15DA6539-D4B0-4809-A3CB-68571FF1A9D3Q36888836-286C47DB-13A3-4309-9450-FCE97A70ECEEQ37180952-D84E9ECE-0745-4B65-9AFB-D818C8623920Q37239485-41FCCE60-A257-4DFB-969C-58C86EC24D63Q38126943-C3CAE80E-7D02-4DF2-8E00-B5932FD46B51Q38191274-213CAD6C-8F74-4C57-9E7E-546AF61688FFQ38588532-777AD53A-F5F2-4716-86EB-BC2E453BBAE3Q38611859-8E4CCEBD-7D6B-41A9-A2D0-26C2E6316899Q38612173-8309A9A7-2CF3-47B6-883A-A239F635467BQ38632884-F331161F-56FE-4EA2-BCEA-81495807EC41Q40227330-580ADBB4-10D6-407F-972F-859600F35F1EQ40612629-E1CE484E-195F-4C8F-89F1-F2B31532AADCQ41002762-7931F77F-78D7-47FB-A430-25E5FAEEA7A3
P2860
A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup.
description
1992 nî lūn-bûn
@nan
1992 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
A comparison of two short inte ...... opean Osteosarcoma Intergroup.
@ast
A comparison of two short inte ...... opean Osteosarcoma Intergroup.
@en
A comparison of two short inte ...... opean Osteosarcoma Intergroup.
@nl
type
label
A comparison of two short inte ...... opean Osteosarcoma Intergroup.
@ast
A comparison of two short inte ...... opean Osteosarcoma Intergroup.
@en
A comparison of two short inte ...... opean Osteosarcoma Intergroup.
@nl
prefLabel
A comparison of two short inte ...... opean Osteosarcoma Intergroup.
@ast
A comparison of two short inte ...... opean Osteosarcoma Intergroup.
@en
A comparison of two short inte ...... opean Osteosarcoma Intergroup.
@nl
P2093
P1476
A comparison of two short inte ...... opean Osteosarcoma Intergroup.
@en
P2093
A T van Oosterom
V H Bramwell
P304
P356
10.1200/JCO.1992.10.10.1579
P407
P577
1992-10-01T00:00:00Z